Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9848

1.

Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome.

Hestiantoro A, Kapnosa Hasani RD, Shadrina A, Situmorang H, Ilma N, Muharam R, Sumapraja K, Wiweko B.

Int J Reprod Biomed (Yazd). 2018 Oct;16(10):623-628.

PMID:
30643854
2.

Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women.

Morshedzadeh N, Saedisomeolia A, Djalali M, Eshraghian MR, Hantoushzadeh S, Mahmoudi M.

Diabetes Metab Syndr. 2019 Jan - Feb;13(1):660-664. doi: 10.1016/j.dsx.2018.11.018. Epub 2018 Nov 15.

PMID:
30641785
3.

Prenatal exposure to testosterone induces cardiac hypertrophy in adult female rats through enhanced Pkcδ expression in cardiac myocytes.

Hou M, Gu HC, Wang HH, Liu XM, Zhou CL, Yang Q, Jiang ZR, Lin J, Wu YM, Wu YT, Sheng JZ, Huang HF.

J Mol Cell Cardiol. 2019 Jan 11. pii: S0022-2828(19)30013-6. doi: 10.1016/j.yjmcc.2019.01.008. [Epub ahead of print]

PMID:
30641088
4.

High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies.

Sun Y, Wang W, Guo Y, Zheng B, Li H, Chen J, Zhang W.

Toxicol Appl Pharmacol. 2019 Jan 11. pii: S0041-008X(19)30016-X. doi: 10.1016/j.taap.2019.01.008. [Epub ahead of print]

PMID:
30641075
5.

Water and soil pollution as determinant of water and food quality/contamination and its impact on female fertility.

Rashtian J, Chavkin DE, Merhi Z.

Reprod Biol Endocrinol. 2019 Jan 13;17(1):5. doi: 10.1186/s12958-018-0448-5. Review.

PMID:
30636624
6.

Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.

Le MT, Le VNS, Le DD, Nguyen VQH, Chen C, Cao NT.

Clin Endocrinol (Oxf). 2019 Jan 13. doi: 10.1111/cen.13934. [Epub ahead of print]

PMID:
30636332
7.

The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.

Hong Y, Yin Y, Tan Y, Hong K, Zhou H.

Med Sci Monit. 2019 Jan 13;25:395-401. doi: 10.12659/MSM.912341.

PMID:
30636259
8.

The influence of the rs1137101 genotypes of leptin receptor gene on the demographic and metabolic profile of normal Saudi females and those suffering from polycystic ovarian syndrome.

Daghestani MH, Daghestani MH, Daghistani MH, Bjørklund G, Chirumbolo S, Warsy A.

BMC Womens Health. 2019 Jan 11;19(1):10. doi: 10.1186/s12905-018-0706-x.

9.

Circulating neuregulin-1 levels in polycystic ovary syndrome.

Arpacı H.

J Obstet Gynaecol. 2019 Jan 11:1-6. doi: 10.1080/01443615.2018.1519530. [Epub ahead of print]

PMID:
30634887
10.

Non-targeted Metabolomic Analysis of Skeletal Muscle in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

Shen Q, Bi H, Yu F, Fan L, Zhu M, Jia X, Kang J.

Mol Reprod Dev. 2019 Jan 11. doi: 10.1002/mrd.23111. [Epub ahead of print]

PMID:
30633842
11.

Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.

Piltonen TT, Giacobini P, Edvinsson Å, Hustad S, Lager S, Morin-Papunen L, Tapanainen JS, Sundström-Poromaa I, Arffman RK.

Fertil Steril. 2019 Jan 7. pii: S0015-0282(18)32223-4. doi: 10.1016/j.fertnstert.2018.11.028. [Epub ahead of print]

12.

Effect of irisin on endometrial receptivity of rats with polycystic ovary syndrome.

Li C, Zhou L, Xie Y, Guan C, Gao H.

Gynecol Endocrinol. 2019 Jan 9:1-6. doi: 10.1080/09513590.2018.1529158. [Epub ahead of print]

PMID:
30626233
13.

The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome.

Özay AC, Emekçi Özay Ö, Okyay RE, Gülekli B.

Gynecol Endocrinol. 2019 Jan 9:1-5. doi: 10.1080/09513590.2018.1520827. [Epub ahead of print]

PMID:
30626230
14.

Serum Metabolomics Analysis of Patients with Polycystic Ovary Syndrome by Mass Spectrometry.

Jia C, Xu H, Xu Y, Xu Y, Shi Q.

Mol Reprod Dev. 2019 Jan 9. doi: 10.1002/mrd.23104. [Epub ahead of print]

PMID:
30624822
15.

Experimental polycystic ovarian syndrome is associated with reduced expression and function of P2Y2 receptors in rat theca cells.

Campos-Contreras AR, Juárez-Mercado AP, González-Gallardo A, Chávez-Genaro R, Garay E, De Ita-Pérez DL, Díaz-Muñoz M, Vázquez-Cuevas FG.

Mol Reprod Dev. 2019 Jan 9. doi: 10.1002/mrd.23106. [Epub ahead of print]

PMID:
30624816
16.

Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality.

Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M.

Gynecol Endocrinol. 2019 Jan 9:1-5. doi: 10.1080/09513590.2018.1534096. [Epub ahead of print]

PMID:
30623695
17.

Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and noninsulin-mediated whole-body glucose uptake.

Ezeh U, Chen IY, Chen YH, Azziz R.

Clin Endocrinol (Oxf). 2019 Jan 8. doi: 10.1111/cen.13931. [Epub ahead of print]

PMID:
30623452
18.

Correlation Between Physiologic and Osteopathic Measures of Sympathetic Activity in Women With Polycystic Ovary Syndrome.

Davis SE, Hendryx J, Bouwer S, Menezes C, Menezes H, Patel V, Speelman DL.

J Am Osteopath Assoc. 2019 Jan 1;119(1):7-17. doi: 10.7556/jaoa.2019.004.

PMID:
30615047
19.

Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome.

Santos Simões R, Carbonel AAF, Borges FT, Baracat MCP, da Silva Sasso GR, Simões MJ, Serafini PC, Soares JM Júnior, Nader HB, Baracat EC.

Gynecol Endocrinol. 2019 Jan 6:1-5. doi: 10.1080/09513590.2018.1505844. [Epub ahead of print]

PMID:
30614308
20.

Circulating Angiopoiet in-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis.

Varikasuvu SR, Panga JR, Satyanarayana MV.

Gynecol Endocrinol. 2019 Jan 7:1-8. doi: 10.1080/09513590.2018.1536736. [Epub ahead of print]

PMID:
30614305

Supplemental Content

Loading ...
Support Center